Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults

Annals of Epidemiology

Volumn 14, Issue 3, 2004, Pages 195-201

  Wu, Tiejian ^a   Sempos, Christopher T ^b   Freudenheim, Jo L ^b   Muti, Paola ^b   Smit, Ellen ^b  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cancer Mortality; Copper; Iron; Nutrition Surveys; Zinc

Indexed keywords

COPPER; IRON; TRANSFERRIN; ZINC;

ADULT; AGED; ARTICLE; BLOOD OXYGEN TENSION; CANCER MORTALITY; CANCER SCREENING; CONTROLLED STUDY; COPPER BLOOD LEVEL; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUTRITION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; UNITED STATES; ZINC BLOOD LEVEL;

EID: 1342302879     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(03)00119-4     Document Type: Article

References (45)

1. Toyokuni S. Iron-induced carcinogenesis: the role of Redox regulation. Free Radic Biol Med. 20:(4):1996;553-566.
2. Lauffer R.B. Iron and Human Disease. 1992;CRC Press, Ann Arbor.
3. Johnson M.A., Fischer J.G. Is copper an antioxidant nutrient? Crit Rev Food Sci Nutr. 32:(1):1992;1-31.
4. Linder M.C., Hazegh-Azam M. Copper biochemistry and molecular biology. Am J Clin Nutr. 63:1996;797s-811s.
5. Stevens R.G., Kalkwarf D.R. Iron, radiation, and cancer. Environ Health Persp. 87:1990;291-300.
6. Swauger J.E., Dolan P.M., Zweier J.L., Kuppusamy P., Kensler T.W. Role of the benzoyloxyl radical in DNA damage mediated by benzoyl peroxide. Chem Res Toxicol. 4:1991;223-228.
7. Massa E.M., Giulivi C. Alkoxyl and methyl radical formation during cleavage of tert-butyl hydroperoxide by a mitochondrial membrane-band redox active copper pool: an EPP study. Free Radic Biol Med. 14:1993;559-565.
8. Clogg M.S., Keen C.L., Hurley I.S. Biochemical pathologies of zinc deficiencies. Mills C.F. Zinc in Human Biology. 1989;International Life Science Institute, London, England.
9. Kaim W., Schwederski B. Bioinorganic Chemistry: Inorganic Elements in the Chemistry of Life. 1994;John Wiley and Sons, New York.
10. Burke J.P., Fenton M.R. Effect of a zinc-deficient diet on lipid peroxidation in liver and tumor subcellular membranes. P Soc Exp Biol Med. 179:1985;187-197.
11. Prasad A.S. Clinical, biochemical and nutritional spectrum of zinc deficiency in human subjects: an update. Nutr Rev. 41:1983;187-208.
12. Duchateau J., Delespesse G., Vrijens R., Collet P. Beneficial effects of oral zinc supplementation on the immune response of old people. Am J Med. 70:1981;1001-1004.
13. Stevens R.G., Jones D.Y., Micozzi M.S., Taylor P.R. Body iron and the risk of cancer. N Engl J Med. 319:1988;1047-1049.
14. Stevens R.G., Graubard B.I., Micozzi M.S., Neriishi K., Blumberg B.S. Moderate elevation of body iron level and increase risk of cancer occurrence and death. Int J Cancer. 56:1994;364-369.
15. Knekt P., Reunanen H., Takkunen H., Aroma A., Heliovara M., Hakulinen T. Body iron stores and risk of cancer. Int J Cancer. 56:1994;379-382.
16. Merk K., Mattsson B., Mattsson A., Hold G., Gullbring B., Bjorkholm M. The incidence of cancer among blood donors. Int J Epidemiol. 19:1990;505-509.
17. Stevens R.G., Beasley R.P., Blumberg B.S. Iron-binding proteins and risk of cancer in Taiwan. J Natl Cancer Inst. 76:1986;605-610.
18. Selby J.V., Friedman G.D. Epidemiologic evidence of an association between body iron stores and risk of cancer. Int J Cancer. 41:1988;677-682.
19. Hann H.W.L., Kim C.Y., London W.T., Blumberg B.S. Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma. Int J Cancer. 43:1989;376-379.
20. Nelson K.G., Davis F.G., Sutter E., Sobin L.H., Kikendall J.W., Bowen P. Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst. 86:1994;455-460.
21. Herrinton L.J., Friedman G.D., Baer D., Selby J.V. Transferrin saturation and risk of cancer. Am J Epidemiol. 142:1995;692-698.
22. Akiba S., Neriishi K., Blot W.T., Kabuto M., Stevens R.G., Kato H., et al. Serum ferritin and stomach cancer risk among a Japanese population. Cancer. 67:1991;1708-1712.
23. Punsar S., Erametse O., Karuonen M.J., Ryhanen A., Hilska P., Vomano H. Coronary heart disease and drinking water. J Chronic Dis. 28:1975;259-287.
24. Schrauzer G.N., White D.A., Schneider C.J. Cancer mortality correlation studies IV. Associations with dietary intakes and blood levels of certain trace elements, notably se-antagonists . Bioinorg Chem. 7:1977;35-56.
25. Halsted J.A., Smith J.C. Plasma-zinc in health and disease. Lancet. 1:1970;322-324.
26. Margalioth E.J., Schenker J.G., Chevion M. Copper and zinc levels in normal and malignant tissues. Cancer. 52:1983;868-872.
27. Magalora T., Bella V., Brtkova A., Beno I., Kudlackova M., Volkovova K. Copper, zinc, super oxide dismutase in precancerous, benign disease and gastric, colorectal and breast cancer. Neoplasma. 46:1999;100-104.
28. Jayadeep A., Raveendran P.K., Kannan S., Nalinakumari K.R., Mathew B., Krishnan N.M., Menum V.P. Serum levels of copper, zinc, iron and ceruplasmin in oral leukoplakia and squamous cell carcinoma. J Exp Clin Cancer Res. 16:1997;295-300.
29. Huang Y.L., Sheu J.Y., Lin T.H. Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem. 32:1999;131-136.
30. Haines A.P., Thompson A.P., Basu T.K., Hunt R. Cancer, retinal binding protein, zinc and copper. Lancet. 1:1982;52-53.
31. Kok F.J., Van Duijn C.M., Hofman A., Van Det Voet G.B., Wolff F.A., Paays C.H., et al. Serum copper and zinc and the risk of death from cancer and cardiovascular disease. Am J Epidemiol. 128:1988;352-359.
32. National Center for Health Statistics. Plan and operation of the Second National Health and Nutrition Examination Survey 1976-80. 1981;National Center for Health Statistics, Hyattsville, MD. (DHHS publication no. (PHS) 81-1317).
33. Center for Disease Control and Prevention. Plan and operation of the NHANES II Mortality Study 1992. 1999;National Center for Health Statistics, Hyattsville, MD. (DHHS publication no. (PHS) 99-1314).
34. Giovanniello T.J., Bendetto G., Palmer D.W., Peter T. Fully and semiautomated methods for the determination of serum iron and total iron-binding capacity. J Lab Clin Med. 71:1968;874-876.
35. Ramsey W.N.M. The determination of the total iron-binding capacity of serum. Clin Chim Acta. 2:1957;221-223.
36. Instrumentation Laboratory, Inc. Clinical application of Atomic Absorption/Emission Spectroscopy. 1972;Instrumentation Laboratory, Inc. Lexington, MA.
37. Perkin-Elmer Corp. Analytical Methods for Atomic Absorption Spectroscopy. 1973;Perkin-Elmer Corp. Norwalk, CT.
38. Centers for Disease Control. Laboratory procedure used by the Clinical Chemistry Division, Centers for Disease Control, in The Second National Health and Nutrition Examination Survey (NHANES II), 1976-1980. 1981;Centers for Disease Control, Atlanta, GA.
39. SUDAAN User's Manual. Release 6.40. 1995;Research Triangle Institute, Chapel Hill, NC.
40. Beaton G.H., Gorey P.H., Steele C. Conceptual and methodological issues regarding the epidemiology of iron deficiency and their implications for studies of the functional consequences of iron deficiency. Am J Clin Nutr. 50:1989;575-588.
41. Ford E.S. Serum copper concentration and coronary heart disease among US adults. Am J Epidemiol. 151:2000;1182-1188.
42. Stampfer M.J., Willett W.C., Speizer F.E., Dysert D.C., Lipnick R., Rosner B., Hennekens C.H. Test of the National Death Index. Am J Epidemiol. 119:1984;837-839.
43. Wentworth D.N., Neaton J.D., Rasmussen W.L. An evaluation of the Social Security Administration Master beneficiary record file and the National Death Index in the ascertainment of vital status. Am J Public Health. 73:1983;1270-1274.
44. Williams B.C., Demitrack L.B., Fries B.E. The accuracy of the National Death Index when personal identifiers other than social security number are used. Am J Public Health. 82:1992;1145-1147.
45. Armstrong B.K., White E., Saracci R. Principles of Exposure Measurement in Epidemiology. 1992;Oxford University Press, New York.